Clinical Trial Update: Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL

View source ↗

Summary

An update on a clinical trial evaluating tyrosine kinase inhibitors combined with low-intensity chemotherapy in Philadelphia chromosome-positive acute lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Versailles Hospital | Conditions: Lymphoblastic Leukemia, Acute | Status: UNKNOWN